↓ Skip to main content

Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report

Overview of attention for article published in Journal of Medical Case Reports, July 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report
Published in
Journal of Medical Case Reports, July 2019
DOI 10.1186/s13256-019-2140-6
Authors

Morgane Broudic-Guibert, Jean-Yves Blay, Léa Vazquez, Alexandre Evrard, Marie Karanian, Sophie Taïeb, Natalie Hoog-Labouret, Céline Mahier Ait Oukhatar, Rania Boustany-Grenier, Antoine Arnaud

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2019.
All research outputs
#10,670,289
of 13,415,438 outputs
Outputs from Journal of Medical Case Reports
#1,272
of 2,293 outputs
Outputs of similar age
#130,326
of 184,215 outputs
Outputs of similar age from Journal of Medical Case Reports
#1
of 1 outputs
Altmetric has tracked 13,415,438 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,293 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 184,215 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them